Researchers share ‘vision for hope’ at ARVO 2016
More than 11,000 clinicians and researchers will gather in Seattle for the latest in cutting-edge vision science at the 2016 meeting of the Association for Research in Vision and Ophthalmology.
Seattle-Against the backdrop of the “Emerald City,” the Association for Research in Vision and Ophthalmology (ARVO) returns to the Washington State Convention Center for its 2016 annual meeting, May 1 to 5.
The largest gathering of eye and vision researchers in the world promises five days of cutting-edge vision science, according to the organization.
Revolving around this year’s theme, “Research: A Vision for Hope,” the meeting will include about 11,000 attendees from more than 75 countries, 6,000 posters, four symposia, and eight major lectures, including an opening and a closing keynote and lectures by ARVO awardees. It also will include special interest group sessions, workshops, social events, and networking opportunities, and a 25,000-square-foot exhibit hall.
SPONSORED: Join us for dinner and diabetic eye disease strategies!
Here are some of the planned highlights of the meeting.
ARVO/Alcon Keynote Series
The ARVO/Alcon Keynote Series is supported by the ARVO Foundation through a contribution from Alcon Laboratories. It includes two events:
-Sunday, noon to 1:15pm
Allan Jones, PhD, CEO, Allen Institutes for Brain Science, will speak on “Components, Computation, Cognition: the Allen Institute for Brain Science 2020 vision.”
The Allen Institute for Brain Science is a non-profit research organization dedicated to providing tools and data for the larger research community. In 2012, it launched a $1 billion, 10-year program to characterize the structure and function of the circuitry of the mouse visual system, along with characterization of cell types in the human brain. This presentation will cover the Allen Institute’s projects and infrastructure, data highlights, and future plans.
-Thursday, 2 to 3:15 p.m.
A panel discussion, “Genetics of Vision: Problems and Solutions,” will be moderated by Russ Van Gelder, MD, PhD. The panel will include:
-Anneke den Hollander, PhD, Institute for Molecular Life Sciences, Radboud University Medical Center, Netherlands
-Debbie Nickerson, PhD, Department of Genome Sciences, University of Washington
-Jay Shendure, MD, PhD, Department of Genome Sciences, University of Washington
-Janey Wiggs, MD, PhD, Department of Ophthalmology, Harvard Medical School
Internal server error